Yuko Tokunaga

715 citations
19 papers · 486 indexed · h-index 13
Topics
Hepatitis B Virus Studies (9 papers)Hepatitis C virus research (9 papers)Liver Disease Diagnosis and Treatment (5 papers)
Partner nations
JapanEgyptUnited States

In The Last Decade

Yuko Tokunaga

19 papers receiving 483 citations

Peers

Yuko Tokunaga
Comparison fields: 5 of 74
  • Molecular Biology 214
  • Hepatology 163
  • Epidemiology 151
  • Genetics 98
  • Immunology 69
Replace Maria Inácia Estevão-Costa with:
Maria Inácia Estevão-Costa Brazil
S J Lo Taiwan
Meir Shamay United States
Jason Lamontagne United States
K Q Hu United States
Zhongliang Shen China
Alyssa B. Long United States
Mary K. Short United States
Nicholas M. Chesarino United States
Shweta Tyagi India
Yuko Tokunaga relative to Maria Inácia Estevão-Costa Brazil Maria Inácia Estevão-Costa's profile →
Citations per field
00.5×4.1×
Maria Inácia Estevão-Costa · 1×
Citations per year

Countries citing papers authored by Yuko Tokunaga

Since Specialization
Citations

This map shows the geographic impact of Yuko Tokunaga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Tokunaga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Tokunaga more than expected).

Fields of papers citing papers by Yuko Tokunaga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Tokunaga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Tokunaga. The network helps show where Yuko Tokunaga may publish in the future.

Co-authorship network of co-authors of Yuko Tokunaga

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Tokunaga. A scholar is included among the top collaborators of Yuko Tokunaga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Tokunaga. Yuko Tokunaga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 6
2 7
3 2
4 60
5 31
6 23
7 8
8 32
9 39
10 3
11 18
12 53
13 73
14 59
15 12
16 4
17 13
18 19
19 24

About Yuko Tokunaga

Yuko Tokunaga is a scholar working on Hepatology, Epidemiology and Cell Biology, having authored 19 papers that have together received 486 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (9 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Hepatology (163 citations), Virology (49 citations) and Epidemiology (151 citations). Yuko Tokunaga has collaborated with scholars based in Japan, Egypt and United States. Frequent co-authors include Takashi Morita, Yasuo Yamazaki, Michinori Kohara, Kyoko Tsukiyama–Kohara, Yukiko Hayashi, Tsunekazu Hishima, Yuichi Hirata, Yukiko Matsunaga, Shinya Obayashi and Chise Tateno. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026